-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

801. Gene Therapies: Poster II

Symposia: Gene Therapies Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 11, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Vera Bzhilyanskaya, BS1*, Julie Brault, PhD, PharmD1*, Siyuan Liu, BS2*, Andres F. Zea Vera, MD, PhD1*, Nikita Kozhushko, MSc1*, Amanda Lawson, BA1*, Uimook Choi, PhD1*, Aaron B. Clark, BS3*, Ronald J. Meis, PhD3*, Michelle Ma, BS1*, Cicera Lazzarotto, PhD4*, Shengdar Tsai, PhD4, Xiaolin Wu, PhD2*, Gary A. Dahl, PhD3*, Jenna Bergerson, MD1*, Alexandra F. Freeman, MD1*, Benjamin Kleinstiver, PhD5*, Harry L Malech, MD1 and Suk See De Ravin, MD, PhD1*

1Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, Bethesda, MD
2Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick, MD
3CELLSCRIPT, LLC, Madison, WI
4Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN
5Center for Genomic Medicine, Department of Pathology, Massachusetts General Hospital, Charlestown, MA

Jesse Green*, Adam Johnson, PhD*, Brian Granger*, Ouwen Liang*, Jesus Moreno*, Andrew Tucker*, Hallee Wright*, Brian Dolinski*, Hanane Ennajdaoui*, Semih Tareen*, Neal van Hoeven, PhD*, Jagesh Shah*, Kutlu Elpek*, Aaron Foster and Terry J. Fry, MD

Sana Biotechnology, Seattle, WA

Claire Booth, MBBS, PhD, MSc1*, Donald B. Kohn, MD2, Myriam Armant, PhD3*, Susan Prockop, MD4, Karen Buckland, PhD5*, Sharat Chandra, MBBS, MD6*, Shanmuganathan Chandrakasan, MD7, Kritika Chetty, MBBS8*, Colleen Dansereau, MSN, RN, CPN9*, Satiro de Oliveira, MD10*, John Everett11*, Diego León Rico, PhD8*, Wendy B. London, PhD12, Jin Hua Xu-Bayford13*, Theodore B. Moore, MD14, Nisha Nagarsheth, PhD15*, Suhag Parikh, MD16*, Dayna Terrazas, RN17*, Shanna L White18*, Axel Schambach, MD, PhD19*, Frederic D. Bushman, PhD20*, Adrian J. Thrasher, MBBS, PhD, FMedSci21*, David A. Williams, MD22 and Sung-Yun Pai, MD23

1Great Ormond Street Hospital, London, ENG, United Kingdom
2Broad Institute of Harvard and MIT, University of California - Los Angeles, Los Angeles, CA
3Boston Children's Hospital, Boston, MA
4Boston Children's Hospital/Dana Farber Cancer Institute, Boston, MA
5University College London/Great Ormond Street Hospital, London, United Kingdom
6Cancer and Blood Disease Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
7Department of Pediatrics; Division of Hematology/Oncology, Emory University, Atlanta, GA
8UCL Great Ormond Street Institute of Child Health, London, United Kingdom
9Gene Therapy Program, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA
10Division of Hematology/Oncology, Department of Pediatrics, University of California, Los Angeles, Los Angeles, CA
11University of Pennsylvania, Pennsylvania
12Boston Children's Hospital, Harvard Medical School, Boston, MA
13Great Ormond Street Hospital For Children NHS Trust, London, GBR
14UCLA Division of Pediatric Hematology, University of California, Los Angeles, Los Angeles, CA
15National Cancer Institute, National Institutes of Health, Bethesda, MD
16Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
17University of California, Los Angeles, Los Angeles, CA
18UCLA, Los Angeles
19Experimental Hematology, Hannover Medical School, Hannover, Germany
20Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
21UCL Great Ormond Street Institute of Child Health and Great Ormond Street Hospital NHS Trust, London, United Kingdom
22Dana-Farber/Boston Children’s Cancer & Blood Disorders Center, Division of Hematology/Oncology, Boston, MA
23National Cancer Institute, Center for Cancer Research, NIH, Bethesda, MD

Rofida Nofal, MD1,2,3*, Yan Yi Chan4*, Sushmita Sen4*, Ulises Juarez Figueroa5*, Hana Willner4*, Matthias Felber6*, Mark Krampf, MS4*, Supawat Thongthip4*, Grace Choi7*, Eileen Nicoletti, MD7*, Jonathan D. Schwartz, MD7, Kenneth I. Weinberg, MD8, Alfredo Rodriguez9*, Rajni Agarwal, MD1,3,10, Maria Grazia Roncarolo, MD, PhD1,3,10 and Agnieszka Czechowicz, MD, PhD1,2,3,11

1Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA
2Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA
3Center for Definitive and Curative Medicine, Stanford University School of Medicine, Stanford, CA
4Stanford University, Stanford, CA
5Laboratorio de Citogenética, Instituto Nacional de Pediatría, Mexico city, Mexico
6Universitäts-Kinderspital Zürich, Zurich, Switzerland
7Rocket Pharmaceuticals, Inc., Cranbury, NJ
8Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA
9Laboratorio de Citogenética, Instituto Nacional de Pediatría, Mexico City, YU, MEX
10Lucile Packard Children’s Hospital, Palo Alto, CA
11Lucile Packard Children’s Hospital, Stanford, CA

Claire Booth, MBBS, PhD1*, Julián Sevilla, MD, PhD2*, Gayatri R. Rao, MD, JD3*, Maria Chitty Lopez, MD3*, Elena Almarza, PhD3*, Dayna Terrazas, RN4*, Josune Zubicaray, PhD2*, Marta González Vicent, MD, PhD2*, Kritika Chetty, MD1*, Grainne O'Toole1*, Jinhua Xu-Bayford1*, Eileen Nicoletti, MD3*, Augustine Fernandes, PhD4*, Caroline Kuo, MD4*, Satiro de Oliveira, MD4*, Theodore B. Moore, MD4, Grace Choi3*, Miriam Zeini, PhD3*, Cristina Mesa-Núñez, PhD3,5,6*, Adrian J. Thrasher, MBBS, PhD, FMedSci1*, Juan A. Bueren, PhD5,6*, Jonathan D. Schwartz, MD3 and Donald B. Kohn, MD4

1UCL Great Ormond Street Institute of Child Health, London, United Kingdom
2Fundación para la investigación Biomédica, Hospital Infantil Universitario Niño Jesús (HIUNJ) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER-ISCIII), Madrid, Spain
3Rocket Pharmaceuticals, Inc., Cranbury, NJ
4University of California, Los Angeles, Los Angeles, CA
5Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER-ISCIII), Madrid, Spain
6Unidad Mixta de Terapias Avanzadas, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain

Adam Giermasz, MD, PhD1, Nathan Visweshwar, MD2*, Thomas J. Harrington, MD3*, Andrew D Leavitt, MD4, Barbara Konkle5, Jeremy Rupon, MD, PhD6, Gregory Di Russo, MD7*, Li-Jung Tseng, PhD, MBA8*, Maria de los Angeles Resa, PhD8*, Florence Ganne9*, Delphine Agathon, PhD9*, Frank Plonski, RN, MA6*, Didier Rouy, MD, PhD10*, Bettina M. Cockroft, MD, MBA11*, Annie Fang, MD, PhD8* and Steven Arkin, MD7

1University of California Davis, Sacramento, CA
2University of South Florida, Tampa, FL
3University of Miami Miller School of Medicine, Miami, FL
4University of California San Fransico, San Francisco, CA
5Bloodworks Northwest and the University of Washington, Seattle, WA
6Pfizer Inc., Collegeville, PA
7Pfizer Inc., Cambridge, MA
8Pfizer Inc., New York, NY
9Pfizer Inc., Paris, France
10Sangamo Therapeutics, Brisbane, CA
11Sangamo Therapeutics, Inc., Brisbane, CA

Giulia Hardouin1*, Panagiotis Antoniou, PhD1*, Pierre Martinucci1*, Tristan Felix, Ph.D.2*, Marta Zoccheddu3*, Anne Chalumeau, Ph.D.2*, Giacomo Frati3*, Sandra Manceau4*, Laure Joseph, MD5*, Oriana Romano6,7*, Marina Cavazzana, MD, PhD8 and Annarita Miccio, PhD1

1Université Paris Cité, Imagine Institute, Laboratory of chromatin and gene regulation during development, INSERM UMR1163, 75015, Paris, France
2Université Paris Cite', Imagine Institute, Laboratory of chromatin and gene regulation during development, INSERM UMR1163, 75015, Paris, France
3Université de Paris, Imagine Institute, Laboratory of chromatin and gene regulation during development, INSERM UMR1163, 75015, Paris, France, Paris, France
4Hôpital Necker, APHP, Paris, FRA
5Biotherapy Department, French National Sickle Cell Referral Center, Hôpital Necker, Assistance-Publique Hôpitaux de Paris, Paris, DC, France
6Department of Life Sciences, University of Modena and Reggio Emilia, 41125, Modena, Italy, Modena, Italy
7Department of Molecular Medicine, University of Padova, 35131, Padova, Italy., Padova, Italy
8Biotherapy Department and Clinical Investigation Center, Assistance Publique Hopitaux de Paris, Inserm, Paris, France

Bhavya S Doshi, MD1,2,3, Ben J Samelson-Jones, MD, PhD1,2,4, Timothy C Nichols5*, Elizabeth P Merricks, PhD5*, Valder R Arruda, MD, PhD1,2,4 and Mary Beth Callan, VMD6*

1Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA
2Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA
3Department of Pediatrics, University of Pennsylvania, Philadelphia, PA
4Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
5Department of Pathology and Laboratory Medicine and the UNC Blood Research Center, University of North Carolina, Chapel Hill, NC
6Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA

Qian Liang, M.D.1*, Ziqi Zhang2*, Xuefeng Wang, M.D.3* and Wenman WU, MD4*

1Ruijin Hospital, Shanghai Jiaotong University School of Medicine, shanghai, China
2Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China
3Faculty of Laboratory Medicine, Ruijin hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, CHN
4Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China, shanghai, PA, China

Thiyagaraj Mayuranathan1*, Gregory A. Newby, PhD2,3,4,5*, Ruopeng Feng, PhD1, Yu Yao, MD6*, Kalin Mayberry, BS6*, Guolian Kang, PhD, MS7, Cicera Lazzarotto, PhD1*, Yichao Li, Ph.D1*, Rachel Levine, PhD1*, Erin Dempsey, BS1*, Shaina N. Porter, PhD8*, Phillip A Doerfler, Ph.D9, Jingjing Zhang, MS9*, Yoonjeong Jang, DVM, PhD1, Senthil Bhoopalan, MBBS, PhD10*, Nikitha Nimmagadda, MSc1*, Akshay Sharma, MD11*, John Tisdale, MD12, Shondra Miller8*, Yong Cheng, PhD1, Shengdar Tsai, PhD1, Mitchell J. Weiss, MD, Ph.D9, David R. Liu, PhD4,5,13* and Jonathan S Yen, PhD1

1Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN
2Broad Institute of MIT and Harvard, Cambridge, MA
3Broad Institute of Harvard and MIT, Harvard University, Cambridge, MA
4Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA
5Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA
6Department of Hematology, St Jude Children’s Research Hospital, Memphis, TN
7Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN
8Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN
9Department of Hematology, St. Jude Children’s Research Hospital, Memphis, TN
10Department of Hematology, St Jude Children's Research Hospital, Memphis, TN
11Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis
12Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
13Howard Hughes Medical Institute, Harvard University, Cambridge, MA

Boya Liu, PhD1, Kevyn Hart2*, Christian Brendel, PhD3*, Donald B. Kohn, MD4,5 and David A. Williams, MD6,7,8

1Department of Hematology/Oncology, Boston Children's Hospital, Boston, MA
2Department of Human Genetics Human Genetics, University of California, Los Angeles, Los Angeles, CA
3Gene Therapy Program, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA
4Department of Microbiology, Immunology and Molecular Genetics, University of California Los Angeles, Los Angeles, CA
5University of California - Los Angeles, Department of Pediatrics, Los Angeles, CA
6Harvard Medical School, Boston, MA
7Dana-Farber/Boston Children’s Cancer & Blood Disorders Center, Division of Hematology/Oncology, Boston, MA
8Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA

Panagiotis Antoniou, PhD1*, Mathieu von Joest, PhD1*, Letizia Fontana1*, Giulia Hardouin1,2*, Pierre Martinucci1*, Marina Cavazzana, MD, PhD2,3 and Annarita Miccio, PhD1

1Université Paris Cité, Imagine Institute, Laboratory of chromatin and gene regulation during development, INSERM UMR1163, 75015, Paris, France
2Biotherapy Clinical Investigation Center, Necker Children's Hospital, Assistance Publique Hopitaux de Paris, Paris, France
3Biotherapy Department, Necker Children's Hospital, Assistance Publique Hopitaux de Paris, Paris, France

Sebastian Treusch, PhD*, Twaritha Vijay, MS*, William M. Matern, PhD*, Kristina Krassovsky, PhD*, Vincent Siu, MS, MBA*, Ian Perrone, MS*, Glen M. Chew, PhD*, Jane Grogan, PhD* and Alana Lerner, PhD*

Graphite Bio, Inc., South San Francisco, CA

Aysha Ansari, MEng1*, Remant Bahadur KC, PhD1*, Mohammad Nasrullah, MSc, BPharm2, Daniel NM Sundaram, PhD1*, Luis Morales Burbano, PhD1*, Joseph Brandwein, MD3, Xiaoyan Jiang, MD, PhD4 and Hasan Uludag, PhD1,2,5*

1Department of Chemical and Materials Engineering, University of Alberta, Edmonton, AB, Canada
2Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada
3Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada
4Terry Fox Laboratory, British Columbia Cancer Agency and Department of Medical Genetics, University of British Columbia, British Columbia, Canada
5Department of Biomedical Engineering, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB, Canada

Alex Alex Pendergast, BSc1*, So Hyun Park, PhD2, Loren A. Binns1*, Celeste K. Kanne1*, Cecile Karsenty, MD3,4, Britney N. Hernandez1*, Byoungyong Yoo2*, Yankai Zhang, PhD1, Gang Bao, PhD2* and Vivien A. Sheehan, MD, PhD1

1Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
2Department of Bioengineering, Rice University, Houston, TX
3Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX
4Baylor College of Medicine, Houston, TX

*signifies non-member of ASH